Treating Early Stage Diabetic Retinopathy

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

244

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Diabetic Retinopathy

Interventions

DRUG

Sinemet CR

25 mg carbidopa/100 mg levodopa

DRUG

placebo

Placebo pill of similar size/shape

Trial Locations (1)

Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur

All Listed Sponsors

collaborator

Emory University

OTHER

lead

VA Office of Research and Development

FED